ESCRS - Star wars & the danger of death stars to the macula ;
ESCRS - Star wars & the danger of death stars to the macula ;

Star wars & the danger of death stars to the macula

“I will now present the author of the presentation with the best title I’ve ever encountered”

Star wars & the danger of death stars to the macula
Leigh Spielberg
Leigh Spielberg
Published: Tuesday, September 12, 2017
[caption id="attachment_9431" align="alignnone" width="1024"] Julio González-López[/caption] “I will now present the author of the presentation with the best title I’ve ever encountered,” said Mandeep Singh, chairman of the Young Retina Specialists (YOURS) Mystery Cases session. Dr Julio González-López, Universidad de Alcalá, Madrid, Spain, appeared on the podium to give his presentation, “Star wars and the danger of death stars to the macula”. His was a case series in which young patients presented with acute central and/or paracentral scotomas. The first two, both of whom were young males of 10 and 14 years of age, had unilateral scotomas and maintained 20/20 visual acuity. The third, a 22-year-old woman, experienced a decreased acuity to 20/30 OD and 20/40 OS. Fundus examination and photography did not show obvious changes, but all three cases demonstrated (para)foveal lesions on OCT of the affected eyes. There was even a full-thickness macular hole present in the second case, that of the 14-year-old boy. The young males admitted to having recently played with high-powered lasers, while the third, an internal medicine resident, admitted to “sun gazing” while trekking in the hills of northern Spain. “She never gave a convincing history of why she was staring at the sun,” said Dr González-López, eliciting laughs from the overflow audience. There are currently no known effective treatments for the extreme retinal phototoxic damage caused by powerful lasers or the sun, and although slow, occasionally partial, improvement in visual acuity can be expected, scotomata may persist. Prevention is paramount.
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular

Long-awaited cellular therapies for corneal endothelial disease enter the clinic.

Read more...

Balancing Innovation and Safety

Ensuring access to advanced cell therapies amid regulatory overhaul.

Read more...

With Eyes on Its Future, ESCRS Celebrates Its Past

Winter Meeting offers opportunities to experiment with new concepts and formats.

Read more...

Best of ESCRS Winter Meeting 2024

Read more...

Following the New Generation

EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.

Read more...

Refocus on Multifocals

Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.

Read more...

Common Myths in Presbyopia Correction

Patient education key to satisfaction with refractive IOLs.

Read more...

Reversible Multifocality

Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.

Read more...

Managing a Cataract Surgery Refractive Miss

Weighing the pros and cons of options for intraocular intervention.

Read more...

Unleashing OCT’s Full Potential

Performance of newest tool for corneal evaluation meets or beats older standard technologies.

Read more...

;